Table 1.

The 7 × 7 contingency tables showing the clustering of samples in the training set and validation set using two sets of gene signatures as determined by Lehmann and colleagues and by us

Lehmann and colleagues
MD Anderson Cancer CenterTraining setBL1BL2MIMMSLLARUNSP
BL1401018009P < 2.2 × 1016
BL20309040
M03490003
IM40036000
MSL03302000
LAR04000260
UNS59400424
Lehmann and colleagues
MD Anderson Cancer CenterValidation setBL1BL2MIMMSLLARUNSP
BL115004001P < 2.2 × 1016
BL20205022
M22210211
IM63030002
MSL18422204
LAR11000150
UNS107182103